etectRx
etectRx is a digital health company that commercializes its proprietary eBurst wireless sensor platform through two systems: the FDA-cleared ID-Cap ingestible sensor for medication adherence monitoring in clinical trials, and the eBrief disposable moisture sensor system for real-time incontinence care in senior living and long-term care facilities.
- Company typePrivate
- Founded2009
- HeadquartersGainesville, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What etectRx does
etectRx is a privately held digital health company headquartered in Alachua, Florida, founded in 2009. It commercializes the proprietary eBurst wireless sensor platform, which enables battery-free, disposable, ingestible, implantable, and wearable sensors for real-time remote health monitoring. The company sells two product systems built on this platform: the FDA-cleared ID-Cap System, an ingestible sensor capsule that transmits ingestion events to a wearable reader (necklace or wrist-worn) and onward to a clinician dashboard for medication adherence monitoring; and the eBrief System, a disposable battery-free moisture sensor insert that pairs with fixed room readers and a care dashboard to alert caregivers of urinary incontinence events in real time. The ID-Cap System is deployed primarily through clinical research partnerships with academic medical centers (University of Colorado, Mass General Brigham, UCLA, University of Cape Town) and pharmaceutical collaborators (Gilead, Pear Therapeutics), with applications in HIV, PrEP, hepatitis C, oncology, and CNS adherence studies.
The eBrief System is sold on a subscription license basis to senior living, assisted living, memory care, and skilled nursing facilities via a structured Early Adopter Program, with sequential pilots at operators including Trilogy Health Services, Mission Health Communities, EdenHill Communities, Mozaic, Black Hills Works, and The Village at Gainesville. Revenue is generated through eBrief subscription contracts (multi-year), ID-Cap hardware and digital pill sales, and clinical research study participation. The company holds 15 issued US patents, maintains HIPAA compliance, and has produced 15+ IRB-validated clinical studies including the NIH-sponsored QUANTI-TAF HIV adherence study demonstrating 95% cumulative adherence across 84 participants over four months.
etectRx firmographics
Firmographics- Name
- etectRx
- Legal name
- etectRx LLC
- Website
- https://etectrx.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- etectRx is a digital health company that commercializes its proprietary eBurst wireless sensor platform through two systems: the FDA-cleared ID-Cap ingestible sensor for medication adherence monitoring in clinical trials, and the eBrief disposable moisture sensor system for real-time incontinence care in senior living and long-term care facilities.
- Ownership category
- akta.pro rank
etectRx industry classification
Industry- Product category
- Digital Health Sensors & Remote Patient Monitoring
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Smart Home & Assistive Technology Installation for Aging-in-Place (HSABAJAI)
Keywords
Where etectRx is headquartered
LocationHeadquarters
- HQ city
- Gainesville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
etectRx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- eBrief System Subscription: The eBrief Intelligent Incontinence Monitoring System is offered through subscription license for senior living, assisted living, memory care, skilled nursing, and related healthcare facilities. The system includes sensors (disposable inserts), readers (fixed devices), monitoring tablets, and dashboard access.
- ID-Cap System (Digital Pills): The FDA-cleared ID-Cap System generates revenue through the sale of digital pills (ingestible sensors), wearable readers, patient apps, and clinician dashboards. Revenue derived from clinical trials, healthcare providers, and pharmaceutical partnerships.
- Clinical Research Partnerships: Collaborations with academic medical centers, hospitals, and research institutions for medication adherence studies using the ID-Cap System. These partnerships support clinical validation and generate revenue through study participation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | eBrief System subscription for healthcare facilities |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels9 records
etectRx product offering
Product offeringCore offering
etectRx develops and commercializes digital health monitoring systems based on its proprietary eBurst wireless sensor technology. Its primary offerings are the FDA-cleared ID-Cap System for medication adherence (ingestible sensor + wearable reader + apps + clinician dashboard) and the eBrief Intelligent Incontinence Monitoring System (disposable battery-free moisture sensors + room readers + care dashboard) sold to senior living, assisted living, and long-term care facilities.
Product overview
etectRx is a digital health company offering a platform-plus-products architecture centered on its proprietary eBurst wireless sensor technology. The core product portfolio consists of two main systems: (1) the ID-Cap System, an FDA-cleared digital pill solution for medication adherence monitoring comprising ingestible sensor capsules, wearable readers (necklace and wrist-worn), patient app, and clinician dashboard; and (2) the eBrief System, an intelligent incontinence monitoring solution for senior living facilities consisting of disposable moisture sensor inserts, room readers, and care dashboard. Both systems are powered by the eBurst platform, which enables battery-free, disposable, ingestible, implantable, and wearable sensors for real-time remote health monitoring across patients, providers, and payers.
Differentiator
Problem solved
Functional benefit
Brands
- eBurst: Novel wireless sensor technology platform enabling real-time remote monitoring for ingestible, implantable, and wearable sensors.
- eBrief
- ID-Cap
Products and services
- eBurst Platform The foundational wireless sensor technology platform powering all etectRx solutions. eBurst enables battery-free, disposable, ingestible, implantable, and wearable sensors for real-time remote health monitoring across patients, providers, and payers.
- ID-Cap System FDA-cleared digital pill system for medication adherence monitoring. Consists of an ingestible sensor capsule (ID-Capsule), wearable reader (necklace or wrist-worn), patient smartphone app, and clinician dashboard. Activates upon ingestion and transmits adherence data to cloud-based servers for clinical applications including HIV treatment, PrEP, hepatitis C, oncology, and mental health medications.
- eBrief System Intelligent incontinence monitoring system for senior living and long-term care facilities. Features disposable battery-free moisture sensors (eBrief Insert) embedded in incontinence products, fixed Bluetooth Room Readers installed in resident rooms, and a Care Dashboard providing real-time alerts when briefs need changing and KPI tracking on wetness events. Designed to address staffing shortages and the heavy caregiver burden in senior care.
- ID-Cap Wrist-Worn Reader Wearable wrist-worn reader component for the ID-Cap System that detects ingestion signals from the ID-Capsule and transmits data to the patient app and cloud server, providing an alternative to the original necklace form factor.
Quantifiable outcome
- 95% cumulative adherence rate in QUANTI-TAF HIV treatment study with 84 participants over 4 months
- +5 more outcomes
Companies that use etectRx
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles3 records
etectRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
etectRx partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and flagship.
- MozaiccoreFirst New York partnership setting the stage for reimbursement potential. eBrief expands partnership footprint to the Northeast market.
- UCLA / The Lundquist Institute at Harbor-UCLA Medical CentercoreClinical study testing ID-Cap System's technology impact on HIV care. Led by researchers from UCLA and The Lundquist Institute at Harbor-UCLA Medical Center.
- Mission Health CommunitiescoreeBrief Early Adopter Program partnership bringing intelligent incontinence monitoring to two Kansas care communities (Rolling Hills Health and Rehab in Wichita and McPherson Health and Rehab in McPherson). Mission Health manages communities in Georgia, Kansas, Minnesota, Missouri, Tennessee, and Wisconsin.
- Black Hills WorkscoreFirst eBrief Early Adopter Program partnership for adults with intellectual and developmental disabilities. Partnership established in seven residential homes in Rapid City, South Dakota, with plans to expand to five additional homes. Black Hills Works serves almost 600 people with disabilities.
- EdenHill CommunitiescoreeBrief Early Adopter Program partnership for innovative incontinence care solution at EdenHill Communities.
- Trilogy Health ServicescoreeBrief Early Adopter Program partnership for deployment of novel intelligent incontinence care solution at Prairie Lakes Health Campus in Noblesville, Indiana. Trilogy serves over 130 senior living communities throughout Kentucky, Indiana, Ohio, Michigan, and Wisconsin.
- The Village at GainesvillecoreFirst industry use of novel eBrief intelligent incontinence monitoring system through a pilot project at Azalea Trace Memory Care Community. The partnership demonstrates the debut application of eBrief for real-time urinary incontinence monitoring in senior living settings.
- University of Cape Town / Mass General BrighamcoreCollaboration on ID-Cap System acceptability study for monitoring medication adherence in individuals with HIV-TB co-infection in South Africa. Mass General Brigham collaborates with University of Cape Town on this research study.
- AARDEX GroupcoreIntegration of AARDEX's adherence analytics software (MEMS) with etectRx's ingestible adherence sensor, creating a comprehensive adherence hardware ecosystem. Based in Liege, Belgium.
- Local Health Inc. (OneroRx)corePartnership to evaluate patient acceptability of ID-Cap System in mental health medication study. Local Health, located in Chicago, recruits patients, dispenses digital pill system, collects data, and publishes survey results. Focus on remote study supported by pharmacy staff.
- Pear TherapeuticsflagshipAgreement to develop up to two product candidates in the CNS space combining Prescription Digital Therapeutics (PDTs) and adherence sensors. First collaboration exploring use of digital pill solutions with PDTs. Pear is the leader in prescription digital therapeutics with FDA-cleared products including reSET, reSET-O, and Somryst.
- University of Colorado Anschutz Medical Campus / NIHflagshipQUANTI-TAF clinical study using ID-Cap System to measure adherence to HIV treatment in 180 patients for over 20,000 doses. NIH-sponsored research (NIAID Award Number R01AI145453) led by Principal Investigator Dr. Jose Castillo-Mancilla. One of the largest and longest digital pill studies in HIV treatment history.
- Brigham and Women's Hospital / The Fenway Institute / Gilead SciencescoreClinical study to understand how adherence can be increased among populations at risk for HIV infection using ID-Cap System. Partnership with Brigham and Women's Hospital, The Fenway Institute at Fenway Health, and Gilead Sciences.
Scale indicators6 records
Recent moves6 records
Expansion highlights7 records
etectRx competitors and assessment
Company assessmentOthers
- AARDEX Group: AARDEX is etectRx's existing adherence-analytics integration partner (MEMS / AARDEX Adherence Hardware Ecosystem). Included as a complementary ecosystem player that jointly delivers adherence data to clinical-trial sponsors rather than as a direct competitor.
Direct peers
- Proteus Digital Health: Proteus pioneered FDA-cleared ingestible sensor pills for medication adherence — the closest historical analog to etectRx's ID-Cap System. Both companies built ingestible event-marker technology for clinical trial and commercial adherence use, making Proteus the canonical comparison despite its 2020 bankruptcy.
- AdhereTech: AdhereTech builds connected pill bottles and dispensers that detect medication adherence events and transmit them to clinicians — directly comparable to etectRx's ID-Cap adherence model via a different form factor, targeting overlapping pharmaceutical and patient populations.
- AiCure: AiCure provides AI-driven patient adherence monitoring used in clinical trials for oncology, CNS and other therapeutic areas, overlapping directly with etectRx's ID-Cap deployment in HIV, PrEP and CNS trials.
- MedMinder: MedMinder offers connected medication dispensers and adherence systems for seniors, managed-care plans and home-care organizations. Comparable to etectRx in serving senior-living facilities and addressing chronic-condition adherence through remote monitoring.
Emerging players
- Pillsy (Cogni+): Pillsy's connected pill-bottle platform tracks dosing and shares adherence data with patients and providers — a narrower, consumer-leaning offering that overlaps with the ID-Cap System's adherence-as-data-service orientation.
- CarePredict: CarePredict markets wearable sensors and AI analytics for senior-living communities to track activities of daily living and detect health changes. Comparable to eBrief for senior-living facilities deploying connected sensors for proactive resident monitoring.
- Health Recovery Solutions: Health Recovery Solutions delivers tablet-based RPM kits and clinician dashboards for post-acute and chronic care, intersecting with etectRx's ID-Cap and eBrief clinician-dashboard workflows.
Broad incumbents
- TENA (Essity): TENA / Essity is the market-leading incontinence-care brand and is exploring smart incontinence monitoring across senior-living customers. Comparable to eBrief in addressing urinary incontinence in care settings, but as part of a much broader global personal-care portfolio.
- Vivify Health: Vivify Health provides an enterprise remote patient monitoring platform used by health systems and payers across chronic-condition cohorts. Comparable to etectRx's connected-care ambitions across medication adherence and remote monitoring.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
etectRx social profiles
Digital presenceetectRx compliance and trust
Trust signalCompliance2 records
etectRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
etectRx leadership team
Management profileNumber of profiles
Profiles11 records
etectRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
etectRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about etectRx
What does etectRx do?
etectRx develops and commercializes digital health monitoring systems based on its proprietary eBurst wireless sensor technology. Its primary offerings are the FDA-cleared ID-Cap System for medication adherence (ingestible sensor + wearable reader + apps + clinician dashboard) and the eBrief Intelligent Incontinence Monitoring System (disposable battery-free moisture sensors + room readers + care dashboard) sold to senior living, assisted living, and long-term care facilities.
Is etectRx a public or private company?
etectRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was etectRx founded?
etectRx was founded in 2009. It employs 11 to 50 people.
Where is etectRx based?
etectRx is headquartered in Gainesville, United States, in the North America region.
How does etectRx make money?
Three revenue lines are on record. eBrief System Subscription is the primary driver. The others are ID-Cap System (Digital Pills) and clinical Research Partnerships.
Who are etectRx's main competitors?
AARDEX Group is listed as an others. Direct peers are Proteus Digital Health, AdhereTech, AiCure and MedMinder. Emerging players are Pillsy (Cogni+), CarePredict and Health Recovery Solutions. Broad incumbents are TENA (Essity) and Vivify Health.
Does etectRx have an API?
No public API is recorded for etectRx.
What industry is etectRx in?
etectRx's product category is Digital Health Sensors & Remote Patient Monitoring. Its primary akta.pro industry code is HLACAPAH, Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.